AMCP CEO Blog: One maxim I hold dear is the value of getting out of the office now and then to see how things are working in the field.
AMCP CEO Blog: Volume to value, quantity to quality: such transitions in health care today are like a rock tossed in a pond. The ripple effects are far-reaching and unstoppable.
AMCP CEO Blog: Whoever said, “May you live in interesting times,” could have been talking about Congressional health care policy debates circa 2017. Never a dull moment!
AMCP CEO Blog: Every morning — like many of you — I settle behind my desk, take a sip of coffee and read the AMCP Daily Dose. This publication, full of valuable news and information, frequently highlights issues and individuals we’re featuring at our Annual Meeting, March 27-30, in Denver. Several caught my eye recently.
AMCP CEO Blog: Who says Congress can’t get anything done…and with bipartisan support to boot? With impressive speed and purpose, the House and Senate overwhelmingly passed the 21st Century Cures Act in the waning days of the 114th Congress.
AMCP CEO Blog: People can accomplish remarkable things when they work toward a common goal. That’s what happened recently when a diverse group of pharmacy stakeholders gathered to develop standardized terms for MTM services.
AMCP CEO Address: The following are excerpts from remarks that AMCP CEO Susan A. Cantrell, RPh, CAE, delivered during the AMCP Nexus 2016 General Session on Oct. 4.
AMCP CEO Blog: There are many ways to measure the health and vitality of a professional association. The most crucial indicators, I’ve found, center on the engagement of an organization’s volunteers.
AMCP CEO Blog: Last week I saw a headline that jumped off the page: “America’s other drug problem: Giving the elderly too many prescriptions” (Washington Post, Aug. 15).
AMPC CEO Blog: “Healing is a matter of time, but it is sometimes also a matter of opportunity,” said the great Hippocrates, father of western medicine.
AMCP CEO Blog: It was only ten years ago when biosimilars were so new that the New York Times described them as “so-called.” As late as five years ago newspapers put quotation marks around the term, as in “biosimilars.”
AMCP CEO Blog: Information is the life blood of managed care pharmacy. Of the “competent and reliable scientific” variety, that is.